News and Trends 8 Dec 2022 MetrioPharm reveals COVID-19 study data …profile in several clinical trials without severe drug-related adverse events or potential for adverse drug-drug interactions. It is suitable for elderly and multi-morbid patients with a wide range of concomitant… December 8, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 7 Oct 2022 Beyond Biotech podcast 17: BIO-Europe, National Hemophilia Foundation …with Travis McCready. BIO-Europe set to start in Leipzig BIO-Europe, one of the biggest biotech events in Europe, is returning with a three day in-person event, followed by a three-day… October 7, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Opinion 1 Nov 2023 Could this be the start of a new era for PI3K drugs? There is hope that a rich biotech pipeline will produce a second generation of PI3K drugs, a type of kinase inhibitor, after issues with the first generation from the class… November 1, 2023 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 30 Oct 2024 Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies? …therapy platform. The broader picture: Biotech’s mission to develop next-generation CAR-T therapies As mentioned previously, issues surrounding safety of CAR-T therapies has primarily been the driver behind biotech companies wanting… October 30, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 19 Jun 2024 MASH candidates make a splash after first drug approval …“serious adverse events” were reported during the trial. Another California-based biopharma that is developing a drug for MASH is 89bio. Its phase 3 candidate pegozafermin is similar to Akero’s EFX…. June 19, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 14 Apr 2023 Researchers explain how some lung tumors avoid immunotherapy …oncogene MYC, which leads to a cascade of events that prevent the action of the gamma interferon inside the cell. Experimental results show this could be a strong and reliable… April 14, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 13 Aug 2018 Orchard Therapeutics Raises €132M to Develop Gene Therapies Orchard Therapeutics raised $150M (€132M) in Series C financing to bring its gene therapies from clinical testing to regulatory approval. The British biotech will use the funding to develop its… August 13, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Inside Labiotech 23 May 2019 See you Labiotech, it has been an awesome ride 🚀 …be a biotech company with a digital component, somewhere in Europe. Let’s see … What does the transition mean for you? In the short term, Labiotech will continue to run… May 23, 2019 - 4 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 10 Feb 2023 Europe approves childhood epilepsy treatment …compared to placebo. The most common treatment-emergent adverse events were decreased appetite, somnolence, fatigue, and pyrexia (fever). No cases of valvular heart disease or pulmonary arterial hypertension were observed. Rima… February 10, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jul 2023 Could a natural sweetener from hydrangeas treat Alzheimer’s disease? …of Integrative Biotechnology, College of Science and Technology, Sahmyook University, along with a group of researchers from Korea, studied the effect of phyllodulcin on Aβ aggregation and various pathological features… July 28, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 24 Mar 2020 Vaccitech’s Prostate Cancer Vaccine Shows Promise in Phase II …nivolumab alone, with no serious adverse events attributable to the vaccine. The therapeutic vaccine candidate is designed to make the immune system target 5T4, a protein present on the surface… March 24, 2020 - 2 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 27 Apr 2022 Cancer Research UK Deploys €700M to Foster Oncology Startups …up around 60 spinout biotech companies. At the start of the Covid-19 pandemic, however, CRUK and many other research charities were hit with shrinking incomes as traditional fundraising methods were… April 27, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email